These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30138450)

  • 1. Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
    Zakaria C; Sean P; Hoang HD; Leroux LP; Watson M; Workenhe ST; Hearnden J; Pearl D; Truong VT; Robichaud N; Yanagiya A; Tahmasebi S; Jafarnejad SM; Jia JJ; Pelin A; Diallo JS; Le Boeuf F; Bell JC; Mossman KL; Graber TE; Jaramillo M; Sonenberg N; Alain T
    PLoS Pathog; 2018 Aug; 14(8):e1007264. PubMed ID: 30138450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
    Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
    Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells.
    Walsh D; Mohr I
    Genes Dev; 2004 Mar; 18(6):660-72. PubMed ID: 15075293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway.
    Bommer UA; Iadevaia V; Chen J; Knoch B; Engel M; Proud CG
    Cell Signal; 2015 Aug; 27(8):1557-68. PubMed ID: 25936523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.
    Satheesha S; Cookson VJ; Coleman LJ; Ingram N; Madhok B; Hanby AM; Suleman CA; Sabine VS; Macaskill EJ; Bartlett JM; Dixon JM; McElwaine JN; Hughes TA
    Mol Cancer; 2011 Feb; 10():19. PubMed ID: 21320304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
    Cope CL; Gilley R; Balmanno K; Sale MJ; Howarth KD; Hampson M; Smith PD; Guichard SM; Cook SJ
    J Cell Sci; 2014 Feb; 127(Pt 4):788-800. PubMed ID: 24363449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1.
    Grosso S; Pesce E; Brina D; Beugnet A; Loreni F; Biffo S
    PLoS One; 2011; 6(12):e29136. PubMed ID: 22216185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.
    Tsukumo Y; Alain T; Fonseca BD; Nadon R; Sonenberg N
    Nat Commun; 2016 Jun; 7():11776. PubMed ID: 27319316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-mTOR, p-4EBP-1 and eIF4E expression in canine prostatic carcinoma.
    Rivera-Calderón LG; Fonseca-Alves CE; Kobayashi PE; Carvalho M; Vasconcelos RO; Laufer-Amorim R
    Res Vet Sci; 2019 Feb; 122():86-92. PubMed ID: 30476726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
    Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes.
    So L; Lee J; Palafox M; Mallya S; Woxland CG; Arguello M; Truitt ML; Sonenberg N; Ruggero D; Fruman DA
    Sci Signal; 2016 May; 9(430):ra57. PubMed ID: 27245614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
    Kosciuczuk EM; Saleiro D; Platanias LC
    Cytokine; 2017 Jan; 89():116-121. PubMed ID: 27094611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
    Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
    Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for the eIF4E binding proteins for the synergistic down-regulation of protein synthesis by hypertonic conditions and mTOR inhibition.
    Clemens MJ; Elia A; Morley SJ
    PLoS One; 2013; 8(8):e71138. PubMed ID: 23940704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor.
    Kobayashi M; Wilson AC; Chao MV; Mohr I
    Genes Dev; 2012 Jul; 26(14):1527-32. PubMed ID: 22802527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
    Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy.
    Zhou L; Goldsmith AM; Bentley JK; Jia Y; Rodriguez ML; Abe MK; Fingar DC; Hershenson MB
    Am J Respir Cell Mol Biol; 2005 Aug; 33(2):195-202. PubMed ID: 15901615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.